Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer. (Q51069613)

28 March 2018

title

Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer. (English)

1 reference

28 March 2018

1 reference

N R West

1

1 reference

28 March 2018

J I Murray

series ordinal

2

1 reference

28 March 2018

P H Watson

series ordinal

3

1 reference

28 March 2018

language of work or name

English

0 references

publication date

15 April 2013

1 reference

28 March 2018

published in

Oncogene

1 reference

28 March 2018

volume

33

1 reference

28 March 2018

issue

12

1 reference

28 March 2018

page(s)

1485-1494

1 reference

28 March 2018

https://scigraph.springernature.com/pub.10.1038/onc.2013.105

exact match

0 references

cites work

Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Cancer stem cells in breast cancer and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Breast cancer stem cells, cytokine networks, and the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Oncostatin M stimulates the detachment of a reservoir of invasive mammary carcinoma cells: role of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Oncostatin M induces cell detachment and enhances the metastatic capacity of T-47D human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Expression profiling technology: its contribution to our understanding of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Oestrogen receptor negative breast cancers exhibit high cytokine content

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Elucidating the altered transcriptional programs in breast cancer using independent component analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Oncostatin M, a multifunctional cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Snail family regulation and epithelial mesenchymal transitions in breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

ERalpha signaling through slug regulates E-cadherin and EMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Progress in understanding reprogramming to the induced pluripotent state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

let-7 regulates self renewal and tumorigenicity of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Effect of training-sample size and classification difficulty on the accuracy of genomic predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Biomarkers for epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Molecular mechanisms of metastasis in breast cancer--clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

S100A7 and the progression of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Generation of breast cancer stem cells through epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Highly sensitive profiling of CD44+/CD24- breast cancer stem cells by combining global mRNA amplification and next generation sequencing: evidence for a hyperactive PI3K pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Sox2 expression in breast tumours and activation in breast cancer stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Two possible mechanisms of epithelial to mesenchymal transition in invasive ductal breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

Expression and function of members of the cytokine receptor superfamily on breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.105

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.105

1 reference

28 March 2018

Dimensions Publication ID

0 references

1 reference

28 March 2018